Home / Events / Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance

Webinar

Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance

July 17, 2024 | 1:00 - 1:45 PM ET

Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique Marsh—Associate Director and Co-Head of Trinity’s Marketing Communications Insights COE, Julie Bayley—Associate Director in Trinity’s Insights practice and Ari King, Associate Consultant.

Key Topics

  • What initiatives are being undertaken at the corporate level to improve trial diversity?
  • How effective are these initiatives?
  • What impact will the FDA’s guidance have on diversity now and in the future?
In Case You Missed It

Click here to read our white paper entitled Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance.


Featuring

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.